US states are regulating artificial intelligence through three genuinely different legal strategies, and multi-state businesses can no longer treat compliance as a single checklist. Colorado's revised AI Act targets algorithmic discrimination in high-risk automated decision-making; Utah's framework centers on transparency, requiring businesses in regulated professions to tell consumers when they are interacting with AI; and California has moved through new regulations under the California Consumer Privacy Act governing automated decision-making technology used to make "significant decisions" about consumers. This article compares what each regime actually requires, where their obligations diverge, and what those differences mean operationally for companies and professionals.

The Fragmented Landscape of US State AI Laws

There is no comprehensive federal AI statute governing how businesses deploy the technology, so states are legislating independently — and they are not legislating consistently. Law firm Bryan Cave Leighton Paisner, which tracks proposed and enacted AI bills across the United States, describes the result as an "uncertain regulatory environment that must be closely monitored and evaluated" for its impact on both risk and the commercial viability of proposed use cases. The practical consequence is that a company's obligations can change with the state line it crosses.

Analysis published in Communications of the ACM frames the problem from the stakeholder side: variation across jurisdictions "adds complexity for all stakeholders, from technology firms to consumers, who must navigate an increasingly complex regulatory landscape." The article points to New York City's independent legislation on AI-driven hiring as evidence that fragmentation extends below the state level, compounding compliance work for companies operating across multiple jurisdictions. Even professional practice is affected: the American Psychological Association notes that some state laws restrict licensed mental health professionals from using AI-powered clinical tools, such as programs that flag patients at increased risk of self-harm, and observes that "the rules vary from state to state, and it's not yet clear how state licensing boards will regulate and manage the fallout from these laws."